Dainippon Sumitomo Pharma Overview

  • Founded
  • 1897
Founded
  • Status
  • Public
  • Employees
  • 6,457
Employees
  • Stock Symbol
  • 4506
Stock Symbol
  • Investments
  • 15
  • Share Price
  • $12.64
  • (As of Thursday Closing)

Dainippon Sumitomo Pharma General Information

Description

Sumitomo Dainippon Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Contact Information

Formerly Known As
Dainippon Pharma
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Food Products
Other Industries
Pharmaceuticals
Other Healthcare
Stock Exchange
TKS
Primary Office
  • 6-8 Doshomachi 2-chome
  • Chuo-ku
  • Osaka, 541-0045
  • Japan
+81 00-0000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dainippon Sumitomo Pharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.64 $12.72 $10.59 - $20.46 $5.02B 397M 1.01M $0.94

Dainippon Sumitomo Pharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 6,743,443 6,743,443 8,700,412 5,975,043
Revenue 4,438,120 4,438,120 4,142,275 4,211,325
EBITDA 924,929 924,929 648,128 911,658
Net Income 374,673 374,673 438,582 482,152
Total Assets 11,592,880 11,592,880 7,528,146 7,619,126
Total Debt 2,757,209 2,757,209 279,042 446,034
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Dainippon Sumitomo Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dainippon Sumitomo Pharma‘s full profile, request access.

Request a free trial

Dainippon Sumitomo Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sumitomo Dainippon Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sale
Food Products
Osaka, Japan
6,457 As of 2020
00000000

000000 0

oris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate ve
0000 000000000
Tokyo, Japan
00000 As of 0000
00.000
00000000 00.000

00000

m dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
000000000000000
Tokyo, Japan
00000 As of 0000
0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dainippon Sumitomo Pharma Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Otsuka Holdings Corporation Tokyo, Japan 00000 00.000 00000000 00.000
00000 Corporation Tokyo, Japan 00000 0000
000000 00000 Corporation Mumbai, India 0000
0000000000 000000 Corporation Doshomachi, Japan 0000
00000000 000000 Corporate Backed or Acquired Tokyo, Japan 00000 000000000000
You’re viewing 5 of 16 competitors. Get the full list »

Dainippon Sumitomo Pharma Executive Team (8)

Name Title Board Seat Contact Info
Hiroshi Nomura Representative Director, President & Chief Executive Officer
Hiroyuki Baba Senior Executive Officer
Nobuhiko Tamura Senior Executive Officer
You’re viewing 3 of 8 executive team members. Get the full list »

Dainippon Sumitomo Pharma Board Members (3)

Name Representing Role Since
000000 0000 Dainippon Sumitomo Pharma Representative Director and Chairman 000 0000
To view Dainippon Sumitomo Pharma’s complete board members history, request access »

Dainippon Sumitomo Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dainippon Sumitomo Pharma Investments & Acquisitions (15)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000000 03-Jan-2020 000000000 000 Biotechnology 0000000 000000
00000000 00000000 30-Dec-2019 0000000000 Drug Discovery
00000000 00000000 30-Dec-2019 000000000000000000 Biotechnology
0000000 00000000 27-Dec-2019 000000000000000000 Biotechnology
Urovant Sciences 27-Dec-2019 Merger/Acquisition Biotechnology
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Dainippon Sumitomo Pharma Subsidiaries (6)

Company Name Industry Location Founded
Enzyvant Sciences Biotechnology Cambridge, MA 2016
0000000 00000000 Biotechnology Brisbane, CA 0000
0000000 00000000 Biotechnology Irvine, CA 0000
000000 00000000000 Drug Discovery Lehi, UT 0000
000000 0000000000 Drug Discovery Cambridge, MA 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Dainippon Sumitomo Pharma Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000000 22-May-2014 00000 00000 00 00.000 Completed
  • 3 buyers
00000000000 000000 27-Mar-2014 00000 00000 00 0000 Completed
  • 000000000 00000000
000000 0000000 31-Jul-2013 00000 0000000 Completed
  • 2 buyers
SanBio Early Stage VC Completed
  • 11 buyers
To view Dainippon Sumitomo Pharma’s complete exits history, request access »